Sotiras to study heterogenity in Alzheimer’s disease
Aristeidis Sotiras, assistant professor of radiology at the School of Medicine, received a five-year $2.8 million grant from the National Institutes on Aging of the National Institutes of Health (NIH) to use machine learning techniques in Alzheimer’s research.
Antidepressant may prevent severe COVID-19, follow-up study indicates
Researchers at Washington University School of Medicine have found that the drug fluvoxamine has been shown, in a pair of studies conducted on two continents, to be an effective treatment for people sick with COVID-19.
Lenschow named Pew Innovation Fund Investigator
Deborah J. Lenschow, MD, PhD, professor at Washington University School of Medicine, has been named an Innovation Fund Investigator by The Pew Charitable Trusts.
International Alzheimer’s clinical trial to test two drugs in combination
The Dominantly Inherited Alzheimer Network Trials Unit (DIAN-TU) at Washington University School of Medicine has announced that it will be targeting two key Alzheimer’s proteins — amyloid and tau — as part of its Tau Next Generation Alzheimer’s prevention trial.
New strategy against treatment-resistant prostate cancer identified
A study from Washington University School of Medicine has identified an RNA molecule that suppresses prostate tumors. According to the research, restoring this so-called long noncoding RNA could be a new treatment strategy.
Cancer moonshot grant funds research into reducing health disparities
Washington University School of Medicine has received a $17 million grant from the National Institutes of Health (NIH) to address disparities in cancer research, treatment and outcomes in underrepresented populations.
Board grants faculty appointments, promotions, tenure
At the university’s recent Board of Trustees meeting, numerous faculty members were appointed or promoted with tenure or granted tenure, with most new roles taking effect Oct. 1.
Popular heart failure drug no better than older drug in sickest patients
A new study led by researchers at Washington University School of Medicine suggests that a widely used heart failure drug named sacubitril/valsartan is no better than valsartan alone in patients with severe heart failure.
Cho receives NIH grant
Jaehyung Cho, professor of medicine at the School of Medicine, received a and a two-year $1.1 million grant from the National Institutes of Health (NIH).
Enhanced therapeutic foods improve cognition in malnourished children
A nutritional supplement popular in the U.S. and added to some types of yogurt, milk and infant formula can significantly improve cognition in severely malnourished children, according to a study led by researchers at Washington University School of Medicine.
View More Stories